Ozempic Stomach Paralysis Lawsuit 2026: Gastroparesis Claims, MDL 3094 & Who Qualifies
You took Ozempic or Wegovy and got gastroparesis — can you sue?
The short answer: if you are in the U.S. and you took a GLP-1 drug such as Ozempic, Wegovy, or Mounjaro and were later diagnosed with gastroparesis (stomach paralysis), severe gastrointestinal injury, or a bowel obstruction, you may be a candidate for a product-liability claim against the manufacturer. The deciding factor is whether your medical records can show drug use, a qualifying diagnosis, and a timeline linking the two. This guide walks U.S. readers through eligibility, MDL 3094 consolidation, what you must prove, costs, and deadlines.
Related: GLP-1 vision loss (NAION) lawsuit MDL 3163 explained →
Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are GLP-1 medications widely used for diabetes and weight management. These drugs slow gastric emptying as part of how they work, and some plaintiffs allege that this effect led to severe, lasting stomach injury and that the makers did not adequately warn of the risk.
What exactly is gastroparesis (stomach paralysis)?
Gastroparesis is a condition in which the stomach muscles move abnormally slowly, so food does not empty into the small intestine at a normal pace. Common symptoms include:
- Chronic nausea and recurrent vomiting
- Feeling overly full after only small amounts of food
- Upper abdominal pain and bloating
- Unexplained weight loss or malnutrition
- Blood-sugar swings (in people with diabetes)
The plaintiffs’ position is that while slowing gastric emptying is a known effect of GLP-1 drugs, in some patients it allegedly led to non-resolving severe gastroparesis or bowel obstruction, and that the labeling did not warn adequately. Whether the drug caused a given injury remains contested as both a scientific and legal matter, and this article does not take a side.
Who qualifies? Use history and diagnosis requirements
Eligibility is confirmed only after an attorney reviews your records, but candidates generally meet these conditions together:
| Requirement | General standard (individual review needed) |
|---|---|
| Drug | Took Ozempic, Wegovy, Rybelsus (semaglutide), Mounjaro, or Zepbound (tirzepatide) |
| Injury | Diagnosed with gastroparesis, bowel obstruction/stricture, or severe chronic vomiting |
| Timing | Onset during or shortly after use, with records showing a temporal link |
| Evidence | Prescription/pharmacy records, diagnostic studies, treatment history |
| Deadline | Your state’s statute of limitations has not expired |
By contrast, claims are harder where there is no proof of drug use, where the diagnosis is unrelated to gastroparesis or obstruction, or where the deadline has already passed. Temporary “the drug upset my stomach” symptoms alone are unlikely to qualify.
What is MDL 3094, and why does it matter?
MDL (Multidistrict Litigation) is a process that pools similar federal cases from across the country before one judge to make discovery efficient. Unlike a class action, each plaintiff keeps an individual case, while common questions (the drug’s risks, what the maker knew, the adequacy of warnings) are handled in one place.
The GLP-1 gastrointestinal injury cases are reported to be consolidated as MDL 3094 in the Eastern District of Pennsylvania. Exact case numbers, scope, and schedules change over time, so confirm the latest status at the JPML (jpml.uscourts.gov) and the presiding court’s docket. This article is general information and does not predict any specific outcome.
A typical MDL proceeds roughly as follows:
- Consolidation and assignment to a transferee judge
- Formation of plaintiffs’ leadership (lead and steering committees)
- Common discovery and document production
- Expert battles over general causation
- Selection of bellwether cases and test trials
- Settlement talks or individual remand based on bellwether results
What do you have to prove, and how?
Product-liability claims typically sort into design defect, manufacturing defect, and failure to warn. In GLP-1 gastrointestinal cases, the adequacy of warnings is often central. The following evidence supports the claim:
| Element | Supporting evidence |
|---|---|
| Drug use | Prescriptions, pharmacy fill records, insurance claims |
| Injury diagnosis | Gastric emptying study, endoscopy/imaging, hospital records |
| Temporal link | Records matching start/stop dates with symptom and diagnosis dates |
| Causation | General and specific causation opinions from GI and pharmacology experts |
| Inadequate warning | Label change history, manufacturer documents, adverse-event reports |
Plaintiffs rarely assemble all of this alone. Firms usually collect and organize records and retain experts. So the most important thing a plaintiff can do is preserve records and give them, complete, to the attorney.
Settlement, costs, and the contingency fee
As of June 2026, the GLP-1 gastrointestinal MDL is reported to be in early and discovery stages, with no fixed settlement grid. That means no one can responsibly promise a number. The table below describes the general cost structure of U.S. product-liability cases, not a guaranteed payout.
| Item | General structure (varies by contract) |
|---|---|
| Fee model | Contingency fee — paid only on a win or settlement |
| Fee percentage | Commonly in the 33%–40% range of recovery (varies by stage/state) |
| If you lose | Usually no fee charged, but how case costs are handled varies |
| Case costs | Record fees, expert fees, court costs — may be deducted separately |
| Damages mix | Medical bills, lost income, future care, pain and suffering, by severity |
When you receive a retainer agreement, check the fee percentage, who bears case costs, what happens if the case loses, and any cost-sharing with other plaintiffs. “Contingency” does not always mean “zero cost ever.”
Statute of limitations: wait too long and the right is gone
The statute of limitations is the deadline to file. It varies by state, often in the two-to-six-year range, and many states use a discovery rule that starts the clock when you knew or reasonably should have known of the injury. If the deadline passes, a claim can be dismissed regardless of its merits.
So if you have been diagnosed with gastroparesis or a bowel obstruction, the safest move is to seek legal advice without delay. Which date triggers the clock and how many years apply differ by case and state, so individual confirmation is essential.
Procedural timeline: from intake to resolution
| Stage | Roughly what happens |
|---|---|
| 1. Intake/review | Free consult, first medical-record review to gauge eligibility |
| 2. Retainer/records | Sign contingency agreement, gather prescription, diagnosis, treatment records |
| 3. Filing/MDL transfer | File complaint; case may transfer into and consolidate with MDL 3094 |
| 4. Discovery | Common document production, causation experts |
| 5. Bellwether trials | Test-trial results set the benchmark for negotiations |
| 6. Settlement or trial | If no settlement, cases may be remanded for individual trial |
The whole process can take years, and MDLs are harder to time than standalone suits. Be cautious of ads promising a fast resolution.
What to check before hiring a lawyer
- Confirm the contingency percentage and case-cost handling in writing
- Ask about experience with drug/diagnosis product-liability and MDL work
- Clarify who pays for record collection and experts
- Be wary of “guaranteed settlement” or “big money in days” ads
- If your deadline is near, do not put off the consultation
This guide provides general information for U.S. residents and plaintiffs. It is not a substitute for advice tailored to your facts and your state’s law.
Related reading
- Ozempic gastroparesis lawsuit MDL 3094 in detail →
- Mounjaro thyroid cancer lawsuit overview →
- GLP-1, Ozempic & Wegovy insurance coverage guide →
- How personal injury lawyer fees work →
This article is for general information only and is not legal or medical advice. Eligibility, deadlines, and damages depend heavily on the facts of each case, so consult a qualified attorney and your medical providers. Verify MDL status and case numbers through the JPML (jpml.uscourts.gov) and the presiding court’s docket.
Who can file an Ozempic stomach paralysis lawsuit?
Generally, people in the U.S. who took a GLP-1 drug such as Ozempic, Wegovy or Mounjaro and were later diagnosed with gastroparesis, severe gastrointestinal injury, or a bowel obstruction may be candidates. You should be able to document the drug use, the diagnosis, and a timeline linking the two. A lawyer reviews your medical records to confirm eligibility.
What is MDL 3094?
MDL stands for Multidistrict Litigation. It pools similar federal cases from across the country before one judge to make discovery efficient, while each plaintiff keeps an individual case. The GLP-1 gastrointestinal injury cases are reported to be consolidated as MDL 3094 in the U.S. District Court for the Eastern District of Pennsylvania. Confirm current status at the JPML site (jpml.uscourts.gov).
What exactly is gastroparesis?
Gastroparesis is a condition where the stomach muscles move abnormally slowly, so food empties from the stomach much later than it should. Symptoms can include chronic nausea and vomiting, early fullness, abdominal pain, and weight changes. Because GLP-1 drugs slow gastric emptying by design, some plaintiffs argue this effect led to severe or lasting injury.
What do I have to prove in this lawsuit?
The core elements are usually that you actually took the GLP-1 drug, that you were diagnosed with a recognized injury such as gastroparesis or a bowel obstruction, that there is a causal or temporal link between the drug and the injury, and that the warnings were inadequate. Prescription records, imaging such as a gastric emptying study, and expert opinions are used to support these points.
How much are the settlements?
As of June 2026, the GLP-1 gastrointestinal MDL is reported to be in early and discovery stages, so there is no fixed settlement grid or guaranteed payout. Amounts vary widely by case based on injury severity, medical bills, lost income, and any permanent effects. No one can promise a specific dollar figure.
How do attorney fees work?
Most U.S. product-liability cases run on a contingency fee. The lawyer takes an agreed percentage of any recovery (commonly in the 33% to 40% range) only if you win or settle, and charges no fee if the case loses. How case costs such as record and expert fees are handled varies by contract, so confirm this before signing.
What is the statute of limitations?
The statute of limitations is the deadline to file, and it differs by state, often falling in the two-to-six-year range. Many states start the clock when you knew or reasonably should have known of the injury under a discovery rule. If the deadline passes, your claim can be barred, so prompt legal advice after diagnosis is important.
Can I still file if I already stopped taking the drug?
Possibly. If you were diagnosed with gastroparesis, a bowel obstruction, or a similar injury during or shortly after use and your records show the link, you may still be reviewed even after stopping the medication. The statute of limitations keeps running, however, so do not delay. Final eligibility depends on a records review.
Does joining the lawsuit cost me anything up front?
Under a contingency arrangement, out-of-pocket cost is usually low at the start, but how case costs are treated if the case loses varies by contract. You should also understand whether participation could affect future care or other matters. Read the fee agreement carefully and ask about every cost before deciding.
Is this a class action or an individual case?
An MDL is not a class action. Your case stays individual, with its own facts and potential value, but shared issues like the drug's risks and the adequacy of warnings are handled together for efficiency. That means outcomes can differ from one plaintiff to another rather than being a single shared judgment.
What records should I gather first?
Start with proof you took the drug, such as prescriptions, pharmacy records, and insurance claims, plus your diagnosis records like a gastric emptying study, endoscopy, imaging, or hospital notes. A clear timeline of when you started, stopped, and were diagnosed is especially valuable. Keep everything and give it all to your attorney.
관련 글
GLP-1 NAION Vision Loss Lawsuit MDL 3163: Ozempic, Wegovy & Trulicity Eye Injury Claims 2026
Social Media Addiction Teen Lawsuit 2026: Who Qualifies and What the MDL Means
Mirena IUD Lawsuit 2026: Pseudotumor Cerebri (IIH) & Migration Claims Against Bayer
Tepezza Hearing Loss & Tinnitus Lawsuit 2026: Who Qualifies, Settlements & Process
NEC Baby Formula Lawsuit 2026 — Premature Infant Necrotizing Enterocolitis Claims Against Similac & Enfamil (MDL 3026)
